Ellie Maas

8PUBLICATIONS
19CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer geneticsPredictive and prognostic markersMolecular medicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 12, 2026
Genotype- dermatological phenotype correlations in CDKN2A, POT1, POLE, BAP1 variant carriers using 3D total-body-imaging.

Ellie J Maas, Sam Kahler, Brigid Betz-Stablein

|Sep 27, 2025
Germline CDKN2A Variant Cascade Testing Across Four Generations Reveals Familial Melanoma-Breast Cancer Genotype-Phenotype Correlation.

Jennifer Berkman, Ellie J Maas, E DeBortoli

|Apr 07, 2025
Prevalence of high-risk melanoma variants in early-onset and/or multiple primary melanoma in an Australian cohort.

Ellie J Maas, Courtney K Wallingford, Emily De Bortoli

|May 09, 2024
POT1 and multiple primary melanomas: the dermatological phenotype.

Ellie J Maas, Emily DeBortoli, Vaishnavi Nathan

|Feb 10, 2024
The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced Senescence.

Caroline Atkinson, Aideen M McInerney-Leo, Martina Proctor

|Aug 28, 2023
MITF E318K: A rare homozygous case with multiple primary melanoma.

Courtney K Wallingford, Ellie J Maas, Antonia Howard

Pageof 2